Stryker Currently Up Nine Consecutive Days, on Pace for Longest Winning Streak Since July 2021 -- Data Talk
CCORF Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $360
Wells Fargo Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $381
Stryker to Buy Pain Therapy Developer Vertos Medical
Sector Update: Health Care Stocks Softer in Afternoon Trading
Sector Update: Health Care
Express News | Stryker: Co & Vertos Medical Will Continue to Operate as Separate Entities & Proceed With Business as Usual Until Deal Closes
Express News | Stryker Announces Definitive Agreement to Acquire Vertos Medical, Inc., Expanding Interventional Pain Management Solutions
Stryker Announces Definitive Agreement To Acquire Vertos Medical, Inc., Expanding Interventional Pain Management Solutions >SYK
AI-Driven Cybersecurity Solutions: Innovations Shaping the Future of Data Protection
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
Stryker to Participate in the 2024 Wells Fargo Healthcare Conference
The Trader: Why the Market's Violent Volatility Didn't Last -- Barron's
How Is The Market Feeling About Stryker?
Those Who Invested in Stryker (NYSE:SYK) Five Years Ago Are up 60%
Stryker (NYSE:SYK) Is Due To Pay A Dividend Of $0.80
Express News | Stryker Announces Definitive Agreement to Acquire Care.ai, a Leading Virtual Care and Ambient Intelligence Solutions Platform
Stryker: Acquisition Will Strengthen Growing Healthcare IT Offering >SYK
Stryker Announces Definitive Agreement To Acquire Care.Ai, A Leading Virtual Care And Ambient Intelligence Solutions Platform >SYK
$100 Invested In Stryker 15 Years Ago Would Be Worth This Much Today